OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease: a systematic review and meta-analysis
Congyuan Ma, Xuanwei Li, Wenlai Li, et al.
International Urology and Nephrology (2023) Vol. 55, Iss. 12, pp. 3167-3174
Closed Access | Times Cited: 8
Congyuan Ma, Xuanwei Li, Wenlai Li, et al.
International Urology and Nephrology (2023) Vol. 55, Iss. 12, pp. 3167-3174
Closed Access | Times Cited: 8
Showing 8 citing articles:
The management of chronic kidney disease not requiring renal replacement therapy in general practice
Simone Kiel, Martha Negnal, Sylvia Stracke, et al.
Deutsches Ärzteblatt international (2025)
Closed Access
Simone Kiel, Martha Negnal, Sylvia Stracke, et al.
Deutsches Ärzteblatt international (2025)
Closed Access
A Drug Safety Evaluation of Dapagliflozin for Diabetic Nephropathies in Patients with Cardiovascular Risk
Aayushi Sood, Aanchal Sawhney, Benjamin Borokhovsky, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Aayushi Sood, Aanchal Sawhney, Benjamin Borokhovsky, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
Sodium glucose transporter 2 inhibitors: Will these drugs benefit non‐diabetic veterinary patients with cardiac and kidney diseases?
Jonathan Elliott, Mark A. Oyama
Journal of Veterinary Pharmacology and Therapeutics (2024)
Open Access | Times Cited: 1
Jonathan Elliott, Mark A. Oyama
Journal of Veterinary Pharmacology and Therapeutics (2024)
Open Access | Times Cited: 1
Comment on “The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease”
I‐Wen Chen, Li-Chen Chang, Kuo‐Chuan Hung
International Urology and Nephrology (2024) Vol. 56, Iss. 6, pp. 2115-2116
Closed Access
I‐Wen Chen, Li-Chen Chang, Kuo‐Chuan Hung
International Urology and Nephrology (2024) Vol. 56, Iss. 6, pp. 2115-2116
Closed Access
Progress of SGLT2 inhibitors in the treatment of common immune-related nephropathies
Guoqian Hu, Yifan Wu, Feng Chen, et al.
International Urology and Nephrology (2024) Vol. 56, Iss. 12, pp. 3807-3813
Closed Access
Guoqian Hu, Yifan Wu, Feng Chen, et al.
International Urology and Nephrology (2024) Vol. 56, Iss. 12, pp. 3807-3813
Closed Access
Cardio-renal protective effect and safety of sodium-glucose cotransporter 2 inhibitors for chronic kidney disease patients with eGFR < 60 mL/min/1.73 m2: a systematic review and meta-analysis
Yaru Zhang, Junhui Luo, Bingxin Li, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access
Yaru Zhang, Junhui Luo, Bingxin Li, et al.
BMC Nephrology (2024) Vol. 25, Iss. 1
Open Access
Impact Of Dapagliflozin To Prevent Contrast Induced Nephropathy After Heart Catheterization And Percutaneous Coronary Intervention
Ahmed Mohammed ElSlalhy, Kamal Ahmed Marghany, Attia Morsy Shokr
Al-Azhar International Medical Journal /Al-Azhar International Medical Journal (2023) Vol. 4, Iss. 11
Open Access | Times Cited: 1
Ahmed Mohammed ElSlalhy, Kamal Ahmed Marghany, Attia Morsy Shokr
Al-Azhar International Medical Journal /Al-Azhar International Medical Journal (2023) Vol. 4, Iss. 11
Open Access | Times Cited: 1
Diabetična ketoacidoza: redek, a resen zaplet zdravljenja z zaviralci SGLT-2 – pregled literature in prikaz serije primerov
Tina Pučnik, Mojca Lunder, Miodrag Janić
Slovenian Medical Journal (2023), pp. 1-8
Open Access
Tina Pučnik, Mojca Lunder, Miodrag Janić
Slovenian Medical Journal (2023), pp. 1-8
Open Access
